Trending

#Apixaban

Latest posts tagged with #Apixaban on Bluesky

Latest Top
Trending

Posts tagged #Apixaban

Preview
Aspirin prices 'rise 1,000%' amid supply shortage A pharmacist says the cost to buy a box of aspirin from suppliers was 38p but is now around £7.

#pharmacy #communitypharmacy #pharmacysupplychains #supplychains #Aspirinprices #pharmacists #Supplychainissues #NationalPharmacyAssociation #NPA #DHSC #aspirinmanufacturing #anticoagulationmedication #apixaban #outofstockmedication #NHSreimbursement #pharmacycontract
zurl.co/Twl24

0 0 0 0
Post image

#Apixaban

1 0 0 0
Video

Eliquis (apixaban) is a prescription blood thinner medication helpful in preventing and treating blood clots. It reduces the risk of stroke and blood clots in patients with non-valvular atrial fibrillation.
#apixaban #Eliquis #stroke prevention medicine

0 0 0 0
Post image

Is There a Generic for Eliquis?

If you’ve been wondering whether a generic version exists, this article lays out the current status, what patent protections are in place, and when generics might become available.

Check out the full info →
dutyfreemeds.com/generic-for-...

-----
#Eliquis #Apixaban

3 1 0 0
Preview
TAHO Pharma Takes a Bold Step with New Anticoagulant Film Submission to FDA TAHO Pharma has submitted a New Drug Application for TAH3311, an innovative Apixaban Oral Dissolving Film, to the U.S. FDA. This product aims to enhance anticoagulant therapy significantly.

TAHO Pharma Takes a Bold Step with New Anticoagulant Film Submission to FDA #Taiwan #Taipei #TAH3311 #Apixaban #TAHO_Pharma

1 0 0 0
Video

SEPTEMBER ISSUE ONLINE 🚩

International Consensus on #LAAC for the Non-implanting Physician

#Apixaban and #Aspirin for #PVT after Laparoscopic Splenectomy for Cirrhotic

#VTE with #Edoxaban: ETNA VTE

#FactorXI Levels in #STEMI Undergoing #PCI

More at: tinyurl.com/mu2d2nbr

2 0 0 0

#Medsky🧪 #publichealth In this cohort study that evaluated 2038 patients who had atrial fibrillation on #apixaban & no history of #stroke, carriers vs noncarriers of 1 or 2 #APOE epsilon ε4 alleles exhibited a 3-fold increase in intracranial hemorrhage risk over a median follow-up of 2.9 years.

1 1 1 0

#riskmanagement #clotting #riskprevention #ResearchMatters #Apixaban #Pradaxa #dabigatran #Eliquis #Xarelto #rivaroxaban #Thrombosis #hematology #ResearchMatters #Apixaban #Pradaxa #dabigatran #Eliquis #Xarelto #rivaroxaban #Thrombosis #hematology

0 0 1 0
Post image

New study, new standard? Reduced-dose apixaban may change the game in cancer-associated thrombosis. Dr. Carrier explains why.
🎙️ Listen: thrombosiscanada.ca/hcp/clot-con...
#CLOTConversations #VTE #Apixaban

0 0 0 0
Preview
Kidney Function and Apixaban | Docwire News Impaired kidney function was the primary predictor of hemorrhage among patients treated with anticoagulant apixaban.

A study presented at #NKFClinicals clarified the association between #kidney function and #apixaban pharmacokinetics, pharmacodynamics, and hemorrhage among patients treated with the drug. #nephsky #nephrology www.docwirenews.com/post/kidney-...

0 0 0 0
Post image

New data alert for oncologists:
Is low-dose apixaban just as effective as standard dosing for preventing VTE recurrence in cancer patients?
This study could shift clinical practice.
Read more 👉 ascopost.com/news/april-2...

#Oncology #ASCO #CancerResearch #VTE #Apixaban #HemOnc

4 0 0 0

#API-CAT study by the #nejm.org.
#accintouch.bsky.social #isth.org
#apixaban #VTE #cancer

0 0 0 0

#API-CAT study by the @nejm.org.
@accintouch.bsky.social @isth.org
#apixaban #VTE #cancer

1 0 0 0
Preview
Vorteile für niedrigdosiertes Apixaban bei Krebskranken Erhalten Krebskranke mit venösen Thrombembolien zur verlängerten Sekundärprophylaxe Apixaban, genügt auch die Hälfte der Standarddosis: Rezidive treten unter 2,5 mg/bd nicht häufiger auf als unter 5,0 mg/bd, das Blutungsrisiko ist jedoch geringer.

Erhalten #Krebs|kranke mit venösen #Thrombembolien zur verlängerten Sekundärprophylaxe #Apixaban, genügt auch die Hälfte der Standarddosis: Rezidive treten unter 2,5 mg/bd nicht häufiger auf als unter 5,0 mg/bd, das Blutungsrisiko ist jedoch geringer. #MedSky #Medizin

1 1 0 0

Do you use, or plan to, apixaban 2.5 mg in cancer patients with VTE?
👀

#VTE #VTESky #HemeSky #IMSky #apixaban @luciaordieres.bsky.social

0 0 0 0
Preview
Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of...

Cancer patients with #VTE can safely continue blood clot prevention with a reduced-dose of #apixaban. A study shows low-dose apixaban led to similar clot recurrence & less bleeding than full-dose treatment. #TCSC #bloodclots #oncology #thrombosis

www.news-medical.net/news/2025032...

3 0 0 1

In pts with active cancer who have completed at least 6 months of anticoagulant Tx:
🔹Extended anticoagulant therapy with reduced-dose #apixaban was non-inferior to full-dose apixaban to prevent recurrent VTE
🔹Reduced dose resulted in a lower incidence of clinically relevant bleeding

#ACC25

4 3 0 1
Post image Post image Post image Post image

Dr. Isabelle Mahe on the extended anticoagulant treatment with a reduced versus full dose #apixaban in patients with cancer-associated #VTE

#ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag #CardioSky

7 4 1 2
Preview
Apixaban: Todo lo que Necesitas Saber sobre Este Anticoagulante ¿Qué es Apixaban y cómo funciona en el tratamiento de la coagulación? Apixaban es un medicamento anticoagulante que pertenece a la clase de los inhibidores directos del factor Xa. Este fármaco se utiliza principalmente... The post Apixaban: Todo lo que…

Apixaban: Todo lo que Necesitas Saber sobre Este Anticoagulante #Apixaban #Anticoagulante #Salud

0 0 0 0
Preview
TAHO Pharmaceuticals Announces Promising Results for TAH3311, A Revolutionary Oral Anticoagulant System TAHO Pharmaceuticals unveils encouraging preliminary results for TAH3311, a groundbreaking orally dissolving anticoagulant film designed for easy use.

TAHO Pharmaceuticals Announces Promising Results for TAH3311, A Revolutionary Oral Anticoagulant System #Taipei #USA #TAHO_Pharmaceuticals #Apixaban #THA3311

0 0 0 0
Preview
TAHO Pharmaceuticals Announces Positive Results for Innovative Oral Anticoagulant TAH3311 TAHO Pharmaceuticals has revealed promising early results from their pivotal study on TAH3311, the world's first oral dissolving film anticoagulant, showing effectiveness similar to traditional tablets.

TAHO Pharmaceuticals Announces Positive Results for Innovative Oral Anticoagulant TAH3311 #Taipei #USA #TAHO_Pharmaceuticals #TAH3311 #Apixaban

0 0 0 0
Preview
TAHO Pharmaceuticals Announces Positive Results for TAH3311, a Breakthrough Oral Dissolving Film Anticoagulant TAHO Pharmaceuticals has reported positive preliminary results from the pivotal study of TAH3311, the world's first oral dissolving film anticoagulant, marking a significant advancement in stroke treatment.

TAHO Pharmaceuticals Announces Positive Results for TAH3311, a Breakthrough Oral Dissolving Film Anticoagulant #Taipei #USA #TAHO_Pharmaceuticals #TAH3311 #Apixaban

0 0 0 0
Preview
TAHO Pharmaceuticals Announces Promising Results for First Oral Anticoagulant ODF TAH3311 TAHO Pharmaceuticals reveals strong preliminary findings from the pivotal study for TAH3311, the world's first oral dissolving film anticoagulant, set to improve patient care.

TAHO Pharmaceuticals Announces Promising Results for First Oral Anticoagulant ODF TAH3311 #Taiwan #Taipei #TAHO_Pharmaceuticals #TAH3311 #Apixaban

0 0 0 0

A new issue of Annals is online now. Read about bleeding risk with #apixaban and #dabigatran, results of interventions to reduce overuse of medical care, a new Annals #BeyondtheGuidelines tackles #AFIB, and more. bit.ly/4iXoo26

0 0 0 0
Post image

I’m supposed to carry a small warning card with me at all times! This lightweight and simple bracelet provides a good backup for that one time when someone needs to know and I can’t tell them. #apixaban #medicalidme

0 0 0 0
Preview
Apixaban to Prevent Infarcts After Stroke in Patients With Atrial Cardiopathy This secondary analysis of a parallel-design double-blind secondary stroke prevention trial in patients with cryptogenic stroke and atrial cardiopathy evaluates the association between apixaban and th...

En pacientes con ictus isquémico criptogénico reciente y cardiopatía auricular, apixaban se asocia con menos infartos encubiertos no lacunares que aspirina #apixaban #stroke jamanetwork.com/journals/jam...

0 0 0 0
Preview
TAHO Pharmaceuticals Successfully Concludes Pivotal Trial of Innovative Oral Dissolving Anticoagulant TAHO Pharmaceuticals announces the successful completion of its pivotal trial for TAH3311, an innovative oral dissolving film anticoagulant, demonstrating its potential in the market.

TAHO Pharmaceuticals Successfully Concludes Pivotal Trial of Innovative Oral Dissolving Anticoagulant #Taiwan #Taipei #TAHO_Pharmaceuticals #TAH3311 #Apixaban

0 0 0 0
Video

#Asundexian εναντίον #Apixaban στην κολπική #μαρμαρυγή

Μεταξύ των ασθενών με κολπική μαρμαρυγή, υπάρχει η ανάγκη για αποτελεσματική #αντιπηκτική #αγωγή που προλαμβάνει το #εγκεφαλικό επεισόδιο, αλλά ενέχει χαμηλότερο κίνδυνο αιμορραγίας από τα του στόματος #αντιπηκτικά άμεσης δράσης. #fibrillation

0 0 0 0
Post image

A randomized controlled trial evaluated the efficacy and safety of #apixaban for prevention of recurrent thrombosis after #thrombectomy of #hemodialysis #vascularaccess

doi.org/10.1016/j.kint.2024.10.023

#MedSky #NephSky #SkyNeph

11 6 0 0
Preview
<em>Journal of Internal Medicine</em> | Wiley Online Library Background Vitamin-K antagonists (VKAs) have widely been replaced by non-VKA oral anticoagulants (NOACs). This includes Austria, Germany and Switzerland, where as VKA, instead of warfarin, the much ...

#Apixaban, #edoxaban and #rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin‐K antagonists: A retrospective German claims data analysis.
#DOAK #NOAK #Phenprocoumon

onlinelibrary.wiley.com/doi/10.1111/...

0 0 0 0